US takes another look at recycling nuclear fuel
Proponents see a reduction in the need for uranium mining and more efficient, cheaper reactors. Opponents see a risk of proliferation.
Physics Today, David Kramer
SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
SHINE Technologies, an advanced nuclear technology company and largest producer of lutetium-177 in North America, today announced a long-term supply agreement with Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals.
SHINE announces first sales of n.c.a. Lu-177
SHINE announces first sales of its non-carrier-added lutetium-177
SHINE closes $80-million
SHINE closes $80-million Series C financing supported by Fidelity Management and Research Company LLC
SHINE Medical CEO Talks Europe Expansion, Future Phases of Company
In addition to creating a company that may soon supply two-thirds of the global demand for radioisotopes used in medical imaging, Wisconsin’s Greg Piefer is moving towards plans to create machinery that will produce clean energy and solve nuclear waste issues. At the...SHINE & IOCB deliver Lu-177 doses to GE
SHINE and IOCB Prague deliver patient dose quantities of lutetium-177 to GE Healthcare, advance therapeutic isotope toward commercialization
Recent Comments